Research News and Research

RSS

FDA assigns PDUFA action date for Orexigen's Contrave NDA review

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 31, 2011 for the review of the Contrave® (naltrexone sustained release (SR)/bupropion SR) New Drug Application (NDA).

17 Jun 2010

St. Jude Medical commences enrollment in LAPTOP-HF study

St. Jude Medical, Inc., a global medical device company, today announced the first enrollment in its LAPTOP-HF (Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy) study. The goal of the LAPTOP-HF study is to demonstrate that the new investigational left atrial pressure (LAP) management system safely and effectively improves outcomes in patients with heart failure (HF).

17 Jun 2010

Kaplan EduNeering, DIA announce strategic alliance to create online educational offerings

Kaplan EduNeering, a leading provider of compliance and knowledge management solutions, and the Drug Information Association (DIA), a global professional member association, announced a new strategic alliance to create online educational offerings for biotechnology, pharmaceutical, academic, and regulatory professionals around the world.

17 Jun 2010

First implantation of PyroTITAN Humeral Resurfacing Arthroplasty performed outside US in Australia

Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Arthroplasty outside the United States. The PyroTITAN was implanted last month in Brisbane, Australia in a 46-year-old patient who reported "immediate pain relief" within 24 hours of surgery. The PyroTITAN Humeral Resurfacing implant is the first commercially-available shoulder arthroplasty prosthesis made of PyroCarbon in the world.

17 Jun 2010

Merge Healthcare announces new distribution agreement with Microdata Tecnologia

Merge Healthcare, a leading health IT solutions provider , today announced a new distribution agreement with Microdata Tecnologia LTDA, a PACS and Medical Imaging Technology manufacturer in Brazil. Under the agreement, Microdata Tecnologia LTDA will have exclusive access to a Portuguese language version of eFilm Workstation, the world's most downloaded software for viewing medical images.

17 Jun 2010

Pharmacyclics increases number of shares to be sold in registered direct offering by 1.9M

Pharmacyclics, Inc. today announced that it has increased the number of shares to be sold in the registered direct offering previously announced on June 15, 2010 by approximately 1.9 million shares, for a total offering of approximately 8 million shares. The increase in the number of shares was due to additional demand from institutional investors who were previously participating in the registered direct offering.

17 Jun 2010

Benefitfocus announces acquisition of BeliefNetworks

Benefitfocus today announced the acquisition of BeliefNetworks, Inc., a leader in transforming real-time data – including consumer behavior, marketing campaign data and social networking conversations – into actionable knowledge for customers. The agreement includes three patent applications and proprietary software code. These assets and the highly-experienced staff of BeliefNetworks are a valuable addition to Benefitfocus, the leader in Software as a Service solutions for health and voluntary benefits.

17 Jun 2010

Biological mechanism associated with remission during pregnancy

During pregnancy, many women experience remission of autoimmune diseases like multiple sclerosis and uveitis. Now, scientists have described a biological mechanism responsible for changes in the immune system that helps to explain the remission.

17 Jun 2010

Constipation prophylaxis in sickle cell patients needs increased attention

Not all patients with sickle cell disease receive laxatives after being treated with narcotics, despite recommendations from a collaborative panel of pediatric experts. These are the findings from a Nationwide Children's Hospital study examining patients from 29 pediatric hospitals, and appearing in Pediatric Blood & Cancer.

17 Jun 2010

2009 H1N1 pandemic influenza vaccine protects against 1918 influenza virus: Report

Mice injected with a 2009 H1N1 pandemic influenza vaccine and then exposed to high levels of the virus responsible for the 1918 influenza pandemic do not get sick or die, report scientists funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

17 Jun 2010

Chelsea presents Northera study data at International Congress on Parkinson's Disease and Movement Disorders

Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.

17 Jun 2010

Study: Low-salt foods may be harder for some people to like than others

Low-salt foods may be harder for some people to like than others, according to a study by a Penn State College of Agricultural Sciences food scientist. The research indicates that genetics influence some of the difference in the levels of salt we like to eat.

17 Jun 2010

Kennedy Krieger Institute orders for Bruker's ultra-high field MRI CryoProbe

Bruker has received an order for the first ultra-high field MRI CryoProbe in North America to be installed at the F.M. Kirby Research Center for Functional Brain Imaging at the Kennedy Krieger Institute in Baltimore, MD. Supported by an American Recovery and Reinvestment Act (ARRA) award to Dr. Peter van Zijl, Director of the Center, the 500 MHz MRI CryoProbe is part of an ultra-high field preclinical MRI BioSpec® system that includes an 11.7 T UltraShield Refrigerated (USR™) magnet and AVANCE™ III electronics.

17 Jun 2010

LWW sponsors symposium on wound care

The 25th Anniversary Clinical Symposium on Advances in Skin & Wound Care: The Conference for Prevention and Healing will be held September 30-October 3, 2010, at the Gaylord Palms Hotel and Convention Center in Kissimee, FL. The symposium is sponsored by Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

17 Jun 2010

Traumatic sexual incidents may cause serious mental health problems: Research

Traumatic sexual incidents may cause serious mental health problems in the years after the events, research at the University of Ulster has shown. Using a unique investigative method, researchers at the University's Psychology Research Institute examined the mental health of women who had visited rape crisis centres - and it showed that sexual trauma plays a role in the development of psychotic disorders such as schizophrenia.

17 Jun 2010

Positive results from Phase I clinical trial of GLYX-13 presented at NCDEU meeting

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that it presented data at the NCDEU 50th Anniversary Meeting showing that its novel mechanism compound GLYX-13 appeared safe in a Phase I trial. GLYX-13 is a glycine site functional partial agonist selective modulator of the NMDA receptor that is being developed initially for use in depression as adjunctive therapy.

17 Jun 2010

Early detection helps prevent nearly thousand deaths from breast cancer each year: Research

NEARLY a thousand deaths from breast cancer could be avoided each year if short term survival rates in England were among the best comparable countries in Europe, according to research presented at the National Cancer Intelligence Network conference today.

17 Jun 2010

Neurocrine Biosciences, Boehringer Ingelheim collaborate to develop GPR119 agonists for Type II diabetes

Neurocrine Biosciences, Inc. announced today that they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of Type II diabetes and other indications. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is responsible for the global development and commercialization of potential GPR119 agonist products.

17 Jun 2010

No evidence on health benefits of oxygen inhalation during heart attack: Researchers

There is no evidence that the common practice of giving patients oxygen to inhale during a heart attack is beneficial, according to a new Cochrane Systematic Review. Until further research is carried out, the researchers say the possibility that giving oxygen may actually increase a patient's risk of dying cannot be ruled out.

17 Jun 2010

Scientific American publishes article on "rebirth" of DNA vaccines

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Scientific American magazine has published in its July issue an article entitled "DNA Drugs Come of Age." The article was co-authored by Dr. David Weiner, Chairman, Scientific Advisory Board, Inovio Pharmaceuticals, and Professor, Department of Pathology & Laboratory Medicine, at the University of Pennsylvania and Dr. Matthew Morrow, a post-doctorate research fellow at University of Pennsylvania.

17 Jun 2010

Research News and Research

FDA assigns PDUFA action date for Orexigen's Contrave NDA review

St. Jude Medical commences enrollment in LAPTOP-HF study

Kaplan EduNeering, DIA announce strategic alliance to create online educational offerings

First implantation of PyroTITAN Humeral Resurfacing Arthroplasty performed outside US in Australia

Merge Healthcare announces new distribution agreement with Microdata Tecnologia

Pharmacyclics increases number of shares to be sold in registered direct offering by 1.9M

Benefitfocus announces acquisition of BeliefNetworks

Biological mechanism associated with remission during pregnancy

Constipation prophylaxis in sickle cell patients needs increased attention

2009 H1N1 pandemic influenza vaccine protects against 1918 influenza virus: Report

Chelsea presents Northera study data at International Congress on Parkinson's Disease and Movement Disorders

Study: Low-salt foods may be harder for some people to like than others

Kennedy Krieger Institute orders for Bruker's ultra-high field MRI CryoProbe

LWW sponsors symposium on wound care

Traumatic sexual incidents may cause serious mental health problems: Research

Positive results from Phase I clinical trial of GLYX-13 presented at NCDEU meeting

Early detection helps prevent nearly thousand deaths from breast cancer each year: Research

Neurocrine Biosciences, Boehringer Ingelheim collaborate to develop GPR119 agonists for Type II diabetes

No evidence on health benefits of oxygen inhalation during heart attack: Researchers

Scientific American publishes article on "rebirth" of DNA vaccines

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News